According to Madrigal Pharmaceuticals 's latest financial reports the company's total assets are $0.64 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $0.64 B | 76.67% |
2022-12-31 | $0.36 B | 32.65% |
2021-12-31 | $0.27 B | -4.76% |
2020-12-31 | $0.28 B | -35.08% |
2019-12-31 | $0.44 B | -8.93% |
2018-12-31 | $0.48 B | 152.42% |
2017-12-31 | $0.19 B | 366.67% |
2016-12-31 | $41.21 M | 11234.48% |
2015-12-31 | $0.36 M | -99.64% |
2014-12-31 | $0.10 B | 5.75% |
2013-12-31 | $95.2 M | -7.59% |
2012-12-31 | $0.10 B | 143.4% |
2011-12-31 | $42.32 M | -21.72% |
2010-12-31 | $54.06 M | 10.54% |
2009-12-31 | $48.91 M | -49.71% |
2008-12-31 | $97.25 M | -20.71% |
2007-12-31 | $0.12 B | 123.86% |
2006-12-31 | $54.78 M | -23.06% |
2005-12-31 | $71.21 M | -46.06% |
2004-12-31 | $0.13 B | 64.23% |
2003-12-31 | $80.38 M | |
2001-12-31 | $2.77 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $2.01 B | 214.06% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $22.68 M | -96.46% | ๐บ๐ธ USA |